BDSX

7.5608.92%
HR

Heinrich Roder

Founder & CTO

Dr. Heinrich Roder, D.Phil, is Senior Vice President of Research & Development of Oxford Cancer Analytics Ltd. Dr. Roder is the founder of Biodesix, Inc. and serves as its Chief Technology Officer. Dr. Roder served as the Chief Technology Officer of Efeckta Technologies Corporation. Recruited from Los Alamos, he served as Efeckta's Chief Technology Officer, leading the Research and Development side of it, patenting applications of Efeckta's Intellectual Property based on the DataJet' perspective and designing functionality for next generation products and services for Efeckta's Strategic Partners. Dr. Roder served as a Director at Biodesix, Inc. He built econometric models for the World Bank and went on to become an eminent theoretical physicist with positions at Univ. of Bayreuth (Germany) and Los Alamos National Laboratory. He has led projects involving the diagonalization of gigadimensional matrices, has done pioneering work in the microscopic mechanisms of colossal magneto resistive perovskites and initiated the first use of large-scale inverse problem techniques in the analysis of neutron scattering data. Dr. Roder is an author and co-author of more than 100 publications and talks in theoretical physics and computational sciences. He is a Rhodes Scholar with a PhD from the University of Oxford. With well-established experiences in liquid biopsy product commercialization and international networks, Heinrich is spearheading product development at Oxford Cancer Analytics.

Positions